Last 12 months
Inside the activity.
0 purchase rows · 38 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 11 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 13 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2022 Filed Jun 24, 2022 20:27 UTC |
Nashat AmirDirector
|
PurchaseCommon Stock | 66,142 | $4.90 | $324,095.80 |
DisclosureSEC source: 0000899243-22-023965 · doc4.xml · nonDerivative · entry 2 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 206,897 F1 · price: The securities were purchased at a combined public offering price of $4.90 per share of common stock, and such combined offering price included accompanying Common Warrants. F4 · ownership.nature: The securities are owned directly by Polaris Venture Partners Founders' Fund VI, L.P. ("PVPFF VI"). PVM VI is the general partner of PVPFF VI. PVM VI may be deemed to have sole voting and dispositive power with respect to the shares held by PVPFF VI and each of the Reporting Person and the other Managing Members may be deemed to have shared voting and dispositive power with respect to the shares held by PVPFF VI. Each of the Reporting Person, PVM VI and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person, PVM VI or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:27 UTC |
Nashat AmirDirector
|
PurchaseCommon Stock | 1,131,850 | $4.90 | $5,546,065.00 |
DisclosureSEC source: 0000899243-22-023965 · doc4.xml · nonDerivative · entry 1 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,540,530 F1 · price: The securities were purchased at a combined public offering price of $4.90 per share of common stock, and such combined offering price included accompanying Common Warrants. F2 · ownership.nature: The securities are owned directly by Polaris Venture Partners VI, L.P. ("PVP VI"). Polaris Venture Management Co. VI, L.L.C. ("PVM VI") is the general partner of PVP VI and PVM VI is managed by its managing members, one of whom is the Reporting Person and a member of the Issuer's Board of Directors (collectively, the "Managing Members"). PVM VI may be deemed to have sole voting and dispositive power with respect to the shares held by PVP VI and each of the Reporting Person and the other Managing Members may be deemed to have shared voting and dispositive power with respect to the shares held by PVP VI. F3 · ownership.nature: (Continued from Footnote 2) Each of the Reporting Person, PVM VI and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person, PVM VI or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 17:04 UTC | GrantStock Option (Right to Buy) · Derivative | 35,750 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073037 · tm2218901-7_4seq1.xml · derivative · entry 2 Parlavecchio Caryn · CIK 0001922346 · CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,750 Underlying: Common Stock · 35,750 shares Expires 2032-06-16 F3 · derivative.exercise_date: Options shall vest and become exercisable in twelve quarterly installments over three years, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date. Read SEC document |
|
| June 16, 2022 Filed Jun 21, 2022 17:04 UTC | GrantCommon Stock | 35,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-073037 · tm2218901-7_4seq1.xml · nonDerivative · entry 1 Parlavecchio Caryn · CIK 0001922346 · CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,050 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in three annual installments over three years, with the first annual installment to vest on June 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 80,050 RSUs. Read SEC document |
|
| June 16, 2022 Filed Jun 21, 2022 17:00 UTC |
Carven Gregory JohnChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,500 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073024 · tm2218901-1_4seq1.xml · derivative · entry 2 Carven Gregory John · CIK 0001815432 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,500 Underlying: Common Stock · 45,500 shares Expires 2032-06-16 F3 · derivative.exercise_date: Options shall vest and become exercisable in twelve quarterly installments over three years, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 17:00 UTC |
Carven Gregory JohnChief Scientific Officer
|
GrantCommon Stock | 45,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-073024 · tm2218901-1_4seq1.xml · nonDerivative · entry 1 Carven Gregory John · CIK 0001815432 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,208 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in three annual installments over three years, with the first annual installment to vest on June 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 38,258 shares of common stock and 89,950 RSUs. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:04 UTC |
Vaishnaw AkshayDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073038 · tm2218901-8_4seq1.xml · derivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2032-06-16 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the first anniversary following the date of grant subject to continued service to the Issuer through such date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:03 UTC |
Myles Edward HCOO & CFO
|
GrantStock Option (Right to Buy) · Derivative | 74,750 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073036 · tm2218901-6_4seq1.xml · derivative · entry 2 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,750 Underlying: Common Stock · 74,750 shares Expires 2032-06-16 F3 · derivative.exercise_date: Options shall vest and become exercisable in twelve quarterly installments over three years, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:03 UTC |
Myles Edward HCOO & CFO
|
GrantCommon Stock | 74,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-073036 · tm2218901-6_4seq1.xml · nonDerivative · entry 1 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,222 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in three annual installments over three years, with the first annual installment to vest on June 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 3,859 shares of common stock and 150,363 RSUs. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:03 UTC |
Mahanthappa Nagesh K.Interim CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073034 · tm2218901-5_4seq1.xml · derivative · entry 2 Mahanthappa Nagesh K. · CIK 0001740430 · Interim CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-16 F3 · derivative.exercise_date: Options shall vest and become exercisable in four quarterly installments over one year, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:03 UTC |
Mahanthappa Nagesh K.Interim CEO and President
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-073034 · tm2218901-5_4seq1.xml · nonDerivative · entry 1 Mahanthappa Nagesh K. · CIK 0001740430 · Interim CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,491 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in their entirety on June 15, 2023; provided the reporting person continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 100,000 RSUs and 380,491 shares owned directly by Mahanthappa - Talland Revocable Trust, for which the reporting person's spouse, Valentine Talland, and reporting person are co-trustees. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:01 UTC |
Gilman MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073026 · tm2218901-2_4seq1.xml · derivative · entry 1 Gilman Michael · CIK 0001291144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2032-06-16 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the first anniversary following the date of grant subject to continued service to the Issuer through such date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:02 UTC |
Ho JunlinGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 45,500 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073032 · tm2218901-4_4seq1.xml · derivative · entry 2 Ho Junlin · CIK 0001868114 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,500 Underlying: Common Stock · 45,500 shares Expires 2032-06-16 F3 · derivative.exercise_date: Options shall vest and become exercisable in twelve quarterly installments over three years, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:02 UTC |
Ho JunlinGeneral Counsel
|
GrantCommon Stock | 45,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-073032 · tm2218901-4_4seq1.xml · nonDerivative · entry 1 Ho Junlin · CIK 0001868114 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,591 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in three annual installments over three years, with the first annual installment to vest on June 15, 2023 and each additional installment to vest annually thereafter; provided the individual continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 28,928 shares of common stock and 91,663 RSUs. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:01 UTC |
Hallal DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001104659-22-073027 · tm2218901-3_4seq1.xml · derivative · entry 1 Hallal David · CIK 0001457477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2032-06-16 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the first anniversary following the date of grant subject to continued service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:35 UTC |
Reed JoshuaDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001104659-22-065955 · tm2216969-7_4seq1.xml · derivative · entry 1 Reed Joshua · CIK 0001746541 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting subject to continued service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:35 UTC |
Vaishnaw AkshayDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001104659-22-065958 · tm2216969-8_4seq1.xml · derivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting subject to continued service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:34 UTC |
Nashat AmirDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001104659-22-065954 · tm2216969-6_4seq1.xml · derivative · entry 1 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting subject to continued service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:34 UTC |
Hallal DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001104659-22-065953 · tm2216969-5_4seq1.xml · derivative · entry 1 Hallal David · CIK 0001457477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting subject to continued service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:33 UTC |
Gilman MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001104659-22-065951 · tm2216969-4_4seq1.xml · derivative · entry 1 Gilman Michael · CIK 0001291144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting subject to continued service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:32 UTC |
Burow KristinaDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001104659-22-065950 · tm2216969-3_4seq1.xml · derivative · entry 1 Burow Kristina · CIK 0001569248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting subject to continued service to the Issuer through such date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:32 UTC |
FLIER JEFFREY S.Director
|
GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001104659-22-065948 · tm2216969-2_4seq1.xml · derivative · entry 1 FLIER JEFFREY S. · CIK 0001740266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-05-26 F1 · derivative.exercise_date: This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 17:16 UTC |
Carven Gregory JohnChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001104659-22-023864 · tm226853-3_4seq1.xml · derivative · entry 2 Carven Gregory John · CIK 0001815432 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-02-14 F3 · derivative.exercise_date: Options vest and become exercisable in sixteen quarterly installments over four years. Vesting commenced on January 1, 2022 and the first vesting event shall occur three months thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 17:16 UTC |
Carven Gregory JohnChief Scientific Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023864 · tm226853-3_4seq1.xml · nonDerivative · entry 1 Carven Gregory John · CIK 0001815432 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,708 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2023 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 38,258 shares of common stock and 44,450 RSUs. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:17 UTC |
Myles Edward HCOO & CFO
|
GrantStock Option (Right to Buy) · Derivative | 57,500 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001104659-22-023866 · tm226853-5_4seq1.xml · derivative · entry 2 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 Underlying: Common Stock · 57,500 shares Expires 2032-02-14 F3 · derivative.exercise_date: Options vest and become exercisable in sixteen quarterly installments over four years. Vesting commenced on January 1, 2022 and the first vesting event shall occur three months thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:17 UTC |
Myles Edward HCOO & CFO
|
GrantCommon Stock | 57,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023866 · tm226853-5_4seq1.xml · nonDerivative · entry 1 Myles Edward H · CIK 0001358219 · COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,472 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2023 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 3,859 shares of common stock and 75,613 RSUs. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:16 UTC |
Ho JunlinGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001104659-22-023865 · tm226853-4_4seq1.xml · derivative · entry 2 Ho Junlin · CIK 0001868114 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2032-02-14 F3 · derivative.exercise_date: Options vest and become exercisable in sixteen quarterly installments over four years. Vesting commenced on January 1, 2022 and the first vesting event shall occur three months thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:16 UTC |
Ho JunlinGeneral Counsel
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023865 · tm226853-4_4seq1.xml · nonDerivative · entry 1 Ho Junlin · CIK 0001868114 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,091 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2023 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 28,928 shares of common stock and 46,163 RSUs. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:15 UTC |
Mahanthappa Nagesh K.Interim CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001104659-22-023863 · tm226853-2_4seq1.xml · derivative · entry 2 Mahanthappa Nagesh K. · CIK 0001740430 · Interim CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-02-14 F3 · derivative.exercise_date: Options shall vest in four quarterly installments over one year, with the first quarterly installment to vest on April 1, 2022 and each additional installment shall vest quarterly thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:15 UTC |
Mahanthappa Nagesh K.Interim CEO and President
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023863 · tm226853-2_4seq1.xml · nonDerivative · entry 1 Mahanthappa Nagesh K. · CIK 0001740430 · Interim CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in their entirety on January 15, 2023; provided the reporting person continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 50,000 RSUs. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:15 UTC |
CHYUNG YUNG H.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $18.08 | $0.00 |
DisclosureSEC source: 0001104659-22-023861 · tm226853-1_4seq1.xml · derivative · entry 2 CHYUNG YUNG H. · CIK 0001740377 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2032-02-14 F3 · derivative.exercise_date: Options vest and become exercisable in sixteen quarterly installments over four years. Vesting commenced on January 1, 2022 and the first vesting event shall occur three months thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:15 UTC |
CHYUNG YUNG H.Chief Medical Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-023861 · tm226853-1_4seq1.xml · nonDerivative · entry 1 CHYUNG YUNG H. · CIK 0001740377 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,496 F1 · shares: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2023 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Company on such vesting date. F2 · balance_after: Consists of 209,183 shares of common stock and 49,313 RSUs. Read SEC document |
| January 18, 2022 Filed Jan 19, 2022 19:00 UTC |
Carven Gregory JohnChief Scientific Officer
|
Tax withholdingCommon Stock | 1,137 | $19.46 | $22,128.75 |
DisclosureSEC source: 0001104659-22-005565 · tm223899-1_4seq1.xml · nonDerivative · entry 1 Carven Gregory John · CIK 0001815432 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,708 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2022. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to an award that was granted on February 1, 2021. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU award vest annually over four years, subject to a continued service relationship with the Issuer on such vesting date. F2 · price: The price reported above represents the weighted average selling price, as the transaction was executed in multiple trades. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected to the SEC staff upon request. F3 · balance_after: Consists of 38,258 shares of common stock and 9,450 RSUs. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:01 UTC |
Myles Edward HChief Financial Officer
|
Tax withholdingCommon Stock | 2,178 | $19.46 | $42,390.20 |
DisclosureSEC source: 0001104659-22-005567 · tm223899-3_4seq1.xml · nonDerivative · entry 1 Myles Edward H · CIK 0001358219 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,972 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2022. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to an award that was granted on February 1, 2021. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU award vest annually over four years, subject to a continued service relationship with the Issuer on such vesting date. F2 · price: This price reported above represents the weighted average selling price, as the transaction was executed in multiple trades . The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected to the SEC staff upon request. F3 · balance_after: Consists of 3,859 shares of common stock and 18,113 RSUs. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:02 UTC |
Ho JunlinGeneral Counsel
|
Tax withholdingCommon Stock | 1,042 | $19.46 | $20,280.34 |
DisclosureSEC source: 0001104659-22-005568 · tm223899-4_4seq1.xml · nonDerivative · entry 1 Ho Junlin · CIK 0001868114 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,591 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2022. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to an award that was granted on February 1, 2021. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU award vest annually over four years, subject to a continued service relationship with the Issuer on such vesting date. F2 · price: The price reported above represents the weighted average selling price, as the transaction was executed in multiple trades. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected to the SEC staff upon request. F3 · balance_after: Consists of 28,928 shares of common stock and 8,663 RSUs. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:01 UTC |
CHYUNG YUNG H.Chief Medical Officer
|
Tax withholdingCommon Stock | 1,421 | $19.46 | $27,656.92 |
DisclosureSEC source: 0001104659-22-005566 · tm223899-2_4seq1.xml · nonDerivative · entry 1 CHYUNG YUNG H. · CIK 0001740377 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,996 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2022. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to an award that was granted on February 1, 2021. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU award vest annually over four years, subject to a continued service relationship with the Issuer on such vesting date. F2 · price: The price reported above represents the weighted average selling price, as the transaction was executed in multiple trades. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected to the SEC staff upon request. F3 · balance_after: Consists of 209,183 shares of common stock and 11,813 RSUs. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 9 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,441 F6 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVM VI. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 8 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F5 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by PVM VI to its members. F4 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person who is a member of the Issuer's Board of Directors, may be deemed to have sole voting and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 7 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 160 F11 · kind: Represents a change in the form of ownership of PVM VI by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVPFF VI. F4 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person who is a member of the Issuer's Board of Directors, may be deemed to have sole voting and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 182 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 6 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 182 F9 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVPFF VI. F10 · ownership.nature: The reportable securities are owned by North Star Profit Sharing Trust for the benefit of the Reporting Person. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 15,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 5 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 140,755 F7 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by Polaris Venture Partners Founders' Fund VI, L.P. ("PVPFF VI") to its partners. F8 · ownership.nature: The reportable securities are owned directly by PVPFF VI. PVM VI is the general partner of PVPFF VI. PVM VI may be deemed to have sole voting and dispositive power with respect to the shares held by PVPFF VI and each of the Reporting Person and the other Managing Members may be deemed to have shared voting and dispositive power with respect to the shares held by PVPFF VI. Each of the Reporting Person, PVM VI and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person, PVM VI or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 7,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 4 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,420 F6 · kind: Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the in-kind distribution of common stock of the Issuer for no consideration by PVM VI. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 55,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 3 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F5 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by PVM VI to its members. F4 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person who is a member of the Issuer's Board of Directors, may be deemed to have sole voting and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 55,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 2 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 55,667 F3 · kind: Represents a change in the form of ownership of PVM VI by virtue of the receipt of shares in the in-kind distribution of common stock of the Issuer for no consideration by PVP VI. F4 · ownership.nature: The reportable securities are owned directly by PVM VI. PVM VI is the general partner of PVP VI and PVM VI is managed by the Managing Members. The Managing Members, one of whom is the Reporting Person who is a member of the Issuer's Board of Directors, may be deemed to have sole voting and dispositive power with respect to the shares held by PVM VI. Each of the Reporting Person and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:32 UTC |
Nashat AmirDirector
|
OtherCommon Stock | 267,631 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045401 · doc4.xml · nonDerivative · entry 1 Nashat Amir · CIK 0001575843 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,408,680 F1 · kind: Represents a distribution, and not a purchase or sale, without additional consideration by Polaris Venture Partners VI, L.P. ("PVP VI") to its partners. F2 · ownership.nature: The reportable securities are owned directly by PVP VI. Polaris Venture Management Co. VI, L.L.C. ("PVM VI") is the general partner of PVP VI and PVM VI is managed by its managing members, one of whom is the Reporting Person and a member of the Issuer's Board of Directors (collectively, the "Managing Members"). PVM VI may be deemed to have sole voting and dispositive power with respect to the shares held by PVP VI and each of the Reporting Person and the other Managing Members may be deemed to have shared voting and dispositive power with respect to the shares held by PVP VI. Each of the Reporting Person, PVM VI and the other Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person, PVM VI or any of the other Managing Members is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 02:28 UTC |
Myles Edward HChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,879 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001104659-21-139527 · tm2133015-1_4seq1.xml · derivative · entry 12 Myles Edward H · CIK 0001358219 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 4,879 shares Expires 2030-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Shares vest over four years, with 25% vesting on July 16, 2021, and the remainder of shares vesting in twelve (12) quarterly installments thereafter, subject to such individual's continued service relationship with the Issuer through each such date. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 02:28 UTC |
Myles Edward HChief Financial Officer
|
SaleCommon Stock | 4,879 | $35.05 | $171,006.02 |
DisclosureSEC source: 0001104659-21-139527 · tm2133015-1_4seq1.xml · nonDerivative · entry 6 Myles Edward H · CIK 0001358219 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,150 F1 · shares: This transaction was effected pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F3 · balance_after: Consists of 24,150 RSUs. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 02:28 UTC |
Myles Edward HChief Financial Officer
|
OtherCommon Stock | 4,879 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-139527 · tm2133015-1_4seq1.xml · nonDerivative · entry 5 Myles Edward H · CIK 0001358219 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,029 F1 · shares: This transaction was effected pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. F9 · price: The shares of common stock were acquired at a price per share of $13.83 as reported in Table II. F10 · balance_after: Consists of 4,879 shares of common stock and 24,150 RSUs. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU award will vest annually over four years, subject to a continued service relationship with the Issuer on such vesting date. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 02:28 UTC |
Myles Edward HChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy · Derivative | 2,351 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001104659-21-139527 · tm2133015-1_4seq1.xml · derivative · entry 11 Myles Edward H · CIK 0001358219 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,379 Underlying: Common Stock · 2,351 shares Expires 2030-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Shares vest over four years, with 25% vesting on July 16, 2021, and the remainder of shares vesting in twelve (12) quarterly installments thereafter, subject to such individual's continued service relationship with the Issuer through each such date. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 02:28 UTC |
Myles Edward HChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,497 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001104659-21-139527 · tm2133015-1_4seq1.xml · derivative · entry 10 Myles Edward H · CIK 0001358219 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,730 Underlying: Common Stock · 47,497 shares Expires 2030-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Shares vest over four years, with 25% vesting on July 16, 2021, and the remainder of shares vesting in twelve (12) quarterly installments thereafter, subject to such individual's continued service relationship with the Issuer through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.